Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Approves St. Jude’s Quadripolar CRT-D Device Following Delay

This article was originally published in The Gray Sheet

Executive Summary

The approval is significant as it marks the entry of the first quadripolar pacing system into the U.S. market. But St. Jude may not get as big of a positive gain from the product as previously expected, analysts suggest.

Advertisement

Related Content

Boston Scientific Will Lean On Quadripolar, S-ICD To Revive Sagging U.S. CRM Sales
St. Jude Outlines Strategy To Revive Pacemaker Business
New Products In Brief
St. Jude Stops Selling CRT Leads Showing Riata-Like Insulation Abrasion
Earnings Calls In Brief
Regulatory News In Brief
St. Jude Revises Timeline For Quadripolar CRT-D Device
St. Jude: CardioMEMS’ Heart Failure Data Reflects Major Opportunity
News In Brief

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT030777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel